[EN] CYCLOBUTYL SUBSTITUTED PYRROLOPYRIDINE AND PYRROLOPYRIMIDINE DERIVATIVES AS JAK INHIBITORS<br/>[FR] DÉRIVÉS PYRROLOPYRIDINE ET PYRROLOPYRIMIDINE À SUBSTITUTION CYCLOBUTYLE UTILISÉS COMME INHIBITEURS DES JAK
申请人:INCYTE CORP
公开号:WO2012068450A1
公开(公告)日:2012-05-24
The present invention provides cyclobutyl substituted pyrrolopyrimidines and pyrrolopyridines of Formula I: wherein X, Y, Z, L, A, R5, n and m are defined above, as well as their compositions and methods of use, that modulate the activity of Janus kinases (JAKs) and are useful in the treatment of diseases related to the activity of JAKs including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.
本发明提供了式I的环丁基取代的吡咯并嘧啶和吡咯并吡啶:其中X、Y、Z、L、A、R5、n和m如上定义,以及它们的组合物和使用方法,用于调节Janus激酶(JAKs)的活性,并且在治疗与JAKs活性相关的疾病中是有用的,例如炎症性疾病、自身免疫疾病、癌症和其他疾病。